Watch Ticker

Durect Corp

Go to Durect Corp Website

$1.86

0.01 (0.81%)

Live

Previous Close

$1.85

Day Range

$1.85 - $1.87

Previous Day Range

$1.83 - $1.88

Market Cap

$57.4 million USD

Day Vol.

258994

Previous Day Vol.

438963

Currency

USD

Primary Exchange

Nasdaq

Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories, which include new chemical entities and propri...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Vandana Singh - Bausch Health Adds Late-Stage Ready Alcohol Liver Disease Drug Candidate In $63 Million DURECT Buyout

Bausch Health will acquire DURECT for $63 million upfront, gaining rights to larsucosterol, a promising drug candidate for treating alcoholic hepatitis, with potential additional milestone payments of up to $350 million.

Related tickers: BHC, DRRX.

Read Full Article

Prnewswire - DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update

DURECT Corporation, a late-stage biopharmaceutical company, will report its fourth quarter and full year 2024 financial results and provide a business update on March 26, 2025. The company is pioneering the development of epigenetic therapies to transform the treatment of serious and life-threatening conditions, including acute organ injury.

Related tickers: DRRX.

Read Full Article

Trending Tickers

Please sign in to view